SUBTANCES FOR THE PROTECTION OF CELLS AND/OR TISSUES
申请人:Losel Ralf
公开号:US20100129436A1
公开(公告)日:2010-05-27
The invention relates to substances that are suitable for protecting cells and/or tissues.
这项发明涉及适用于保护细胞和/或组织的物质。
A new convenient method for the esterification of carboxylic acids
作者:Sunggak Kim、Youn Chul Kim、Jae In Lee
DOI:10.1016/s0040-4039(00)86271-1
日期:1983.1
Reaction of carboxylic acids with equimolar amounts of alkyl chloroformate and triethylamine in the presence of a catalytic amount of 4-dimethylaminopyridine affords the corresponding esters in high yields without the formation of the symmetrical anhydride in most carboxylic acids.
A new synthesis of phosphoramidates: inhibitors of the key bacterial enzyme aspartate semi-aldehyde dehydrogenase
作者:Luke A. Adams、Russell J. Cox、Jennifer S. Gibson、M. Belén Mayo-Martín、Magnus Walter、William Whittingham
DOI:10.1039/b206199f
日期:——
A new, mild and high yielding synthesis of phosphoramidates is described: potassium salts of carboxylic acids are treated with ethylchloroformate and the resulting activated anhydride-carbonates are then treated with LiNHP(O)(OEt)2in situ—the methodology is especially suited to acid sensitive systems featuring BOC, tBu or acetal protecting groups.
New C-3′ hydroxamate-substituted and more lipophilic cyclic hydroxamate cephalosporin derivatives as a potential new generation of selective antimicrobial agents
作者:Marvin J. Miller、Gaiying Zhao、Sergei Vakulenko、Scott Franzblau、Ute Möllmann
DOI:10.1039/b612475e
日期:——
Syntheses of a series of new C-3â² hydroxamate-substituted cephalosporin derivatives with potent antibacterial and media-dependent anti-TB activity are described.
[EN] LIPOPHILIC DOPAMINE DERIVATIVES AND THEIR USE<br/>[FR] DÉRIVÉS DE DOPAMINE LIPOPHILES ET LEUR UTILISATION
申请人:NOVALIQ GMBH
公开号:WO2013034457A1
公开(公告)日:2013-03-14
The invention provides novel lipophilic dopamine derivatives with improved stability and physiological half-life. The compounds may be used for organ and tissue preservation during storage and transport, or in the pre-treatment of organ and tissue donor or recipients. Moreover, they may be used as therapeutic agents for the prevention or treatment of ischaemia-related pathological conditions.